Inventor · disambiguated record
Michael W. Fanger
Also filed as: FANGER MICHAEL W
11 granted patents·4 pending applications·728 citations·filing 1987–2005
94Inventor score
Top patents by PatentIndex Score
15 records- 0195US5833985ABispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicityMEDAREX INC·Filed 1995·Granted Nov 10, 1998·163 cites·8 claims
- 0294US4954617AMonoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytesDARTMOUTH COLLEGE·Filed 1987·Granted Sep 4, 1990·198 cites·8 claims
- 0388US6096311AMethods for use of monoclonal antibodies specific for the high affinity Fc receptor for immunoglobulin GMEDAREX·Filed 1997·Granted Aug 1, 2000·91 cites·6 claims
- 0488US6071517ABispecific heteroantibodies with dual effector functionsMEDAREX INC·Filed 1994·Granted Jun 6, 2000·85 cites·44 claims
- 0578US6248332B1Targeted immunostimulation with bispecific reagentsMEDAREX INC·Filed 1994·Granted Jun 19, 2001·41 cites·27 claims
- 0677US5635600ABifunctional and heteroantibodies specific for the high affinity Fc receptor for immunoglobulin G on human mononuclear phagocytesDARTMOUTH COLLEGE·Filed 1994·Granted Jun 3, 1997·35 cites·28 claims
- 0776US5762930ABispecific reagents for redirected targeting of human lipoproteinsDARTMOUTH COLLEGE·Filed 1993·Granted Jun 9, 1998·34 cites·26 claims
- 0874US6258358B1Targeted immunostimulation with bispecific reagentsMEDAREX INC·Filed 1995·Granted Jul 10, 2001·32 cites·20 claims
- 0962US6018031ABinding agents specific for IgA receptorDARTMOUTH COLLEGE·Filed 1996·Granted Jan 25, 2000·17 cites·9 claims
- 1060US2004141998A1Targeted immunostimulation with bispecific reagentsFiled 2003·Application pending·0 cites
- 1159US2005240012A1Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicityBALL EDWARD D·Filed 2005·Application pending·0 cites
- 1257US5897861ABispecific reagents for AIDS therapyMEDAREX INC·Filed 1994·Granted Apr 27, 1999·25 cites·14 claims
- 1356US2001048922A1Targeted immunostimulation with bispecific reagentsMEDAREX INC·Filed 2001·Application pending·0 cites
- 1453US2001005747A1Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicityMEDAREX INC·Filed 2000·Application pending·0 cites
- 1545US5610057AMonoclonal antibody specific for IgA receptorMEDAREX INC·Filed 1994·Granted Mar 11, 1997·7 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Michael W. Fanger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →